Author

Martin Mayora Neto

Medway School of PharmacyORCID 0000-0002-5331-5554Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 5 Research Focus:host-pathogen & immune response· 3 Research Focus:drug response / drug discovery· 2 Organism:human· 2 Assay:proteomics· 2 Organism:mouse· 1 Organism:rat· 1

Frequent Co-Authors

Kelly A.S. da CostaiD· 5 shared Nigel James TempertoniD· 5 shared Claudia Maria TrombettaiD· 3 shared Janet M. DalyiD· 3 shared Maria MarottaiD· 3 shared Emanuele MontomoliiD· 2 shared Helen EverettiD· 2 shared Meshach MainaiD· 2 shared

Activity by Year

2025-2026 · peak 3/yr

Co-Author Collaboration Network

10 top collaborators · 38 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

5 shared papersImmunology

Kelly A.S. da CostaORCID

Mutual co-authors in cluster

Author profile →

5 papers

Recent·Most cited

Pseudotyped virus-based platform and structural analysis reveal potential cross-reactivity sites between influenza C and D viruses

Maria Marotta, Shahid Rowles-Khalid, Martin Mayora Neto, Janet M. Daly, Pauline M. van Diemen, Helen Everett, Emanuele Montomoli, Claudia Maria Trombetta, Nigel James Temperton, Kelly da Costa

The paper uses pseudotyped viruses and structural analysis to identify shared antigenic sites between influenza C and D viruses, suggesting potential for cross-protective vaccines.

bioRxiv · Jul 20, 2026 · PreprintImmunology

Serine proteases are required to activate influenza D virus haemagglutinin-esterase fusion (HEF) protein

Meshach Maina, Junsen Zhang, Martin Mayora Neto, Kelly da Costa, Eva Böttcher‐Friebertshäuser, Edward C. Hutchinson, Maria Marotta, Claudia Maria Trombetta, Simon D. Scott, Nigel James Temperton, Janet M. Daly

This study identifies HAT and swAT as proteases that activate ICV and IDV HEF proteins, showing that protease specificity does not restrict IDV replication in the human upper respiratory tract.

bioRxiv · Apr 16, 2026 · PreprintMicrobiology

A Novel dual Influenza virus and SARS-CoV-2 neutralisation assay

Kelly A.S. da Costa, Martin Mayora Neto, Sururat F Adigun, Titilola T Shobande, Derrick Amoaka-Tawiah, Shazeea Masud, Temitavo O Basaru-Sanni, P. Copoomootoo, Arwel Wyn Jones, Glen Davison, Mariana Pjechová, Andrew David Miller, Miroslav Fajfr, Daniel Růžek, Nigel James Temperton

This paper introduces a dual neutralisation assay for SARS-CoV-2 and influenza viruses, demonstrating its sensitivity and specificity in detecting neutralising antibodies.

bioRxiv · Sep 19, 2025 · PreprintImmunology

Development and optimisation of Influenza C and Influenza D pseudotyped viruses

Maria Marotta, Martin Mayora Neto, Janet M. Daly, Meshach Maina, Pauline M. van Diemen, Helen Everett, Maria Stella Lucente, Michele Camero, Emanuele Montomoli, Claudia Maria Trombetta, Kelly da Costa, Nigel James Temperton

The paper develops and optimizes pseudotyped viruses for influenza C and D to enable antiviral screening and sero-epidemiological studies.

Journal of Virological Methods · Aug 23, 2025Peer-reviewedImmunology

Cross-Neutralizing Monoclonal Antibodies with Broad Activity Against Human and Bat-Derived SARS-Related Coronaviruses

Martin Mayora Neto, Kelly da Costa, Diego M. Cantoni, Mariliza Derveni, Edward Wright, Heinz Hoschuetzky, Franz Kaufmann, Petra Schuessler, Nigel James Temperton

The paper identifies monoclonal antibodies that neutralize multiple SARS-CoV-1, SARS-CoV-2 variants, and bat coronaviruses, with one antibody showing broad cross-reactivity.

bioRxiv · Aug 14, 2025 · PreprintMicrobiology